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a  b  s  t  r  a  c  t
Transcatheter  aortic  valve  implantation  has  been  increasingly  used  in symptomatic  patients  with  severe
aortic  stenosis  who  are inoperable  or at high  risk. However  it remains  associated  with  the  potential
for  serious  complications.  We  report  a case  in  which  an  Edwards  Sapien  (Edwards,  Irvine,  CA,  USA)
valve  prosthesis  dislocated  to the  left ventricular  outﬂow  tract  with  hemodynamic  collapse  6  h followingeywords:
ortic stenosis
ranscatheter aortic valve implantation
islocation
implantation.
<Learning  objective:  Transcatheter  aortic  valve  implantation  (TAVI)  is  an  alternative  method  to  surgical
aortic  valve  replacement  in  patients  with  severe  aortic  stenosis  and  high  surgical  risk.  Despite  continuous
improvements  in operators’  expertise  and device  technology,  it remains  associated  with  the  potential  for
serious complications  such  as  valve  dislocation.  Dislocation  after TAVI  is  a  life-threatening  complication
that  requires  immediate  diagnosis  and  treatment.>
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Transcatheter aortic valve implantation (TAVI) is now consid-
red to be a therapeutic option for patients with severe aortic
tenosis (AS) who are inoperable or at high risk for conventional
ortic valve surgery [1]. It was ﬁrst described in 2002 by Cribier
t al. [2]. Although the procedure has a >95% success rate, it remains
ssociated with life-threatening complications different from con-
entional aortic valve surgery and different from other catheter
rocedures such as dislocation, valve embolization, stroke, perfo-
ation of the aorta, and the obstruction of coronary ostia. These
omplications are also difﬁcult to control in contrast to conven-
ional surgery [3,4].
ase report
A 79-year-old man  presented with exertional dyspnea and
nown severe AS that was refused for surgery in the past. His
ast medical history included coronary artery bypass grafting [left
nternal mammary artery (LIMA) to the left anterior descending
rtery (LAD) and saphenous vein grafts to diagonal and right coro-
ary arteries], hypertension, and diabetes mellitus type 2. Over
he preceding 3 months he had been complaining of worsening
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dyspnea and dizziness and was  becoming increasingly functionally
incapacitated. His New York Heart Association (NYHA) functional
class was 3. Transthoracic echocardiography (TTE) demonstrated
a severe calciﬁed AS with a valve area 0.6 cm2, mean gradient
45 mmHg, and left ventricular ejection fraction (LVEF) 30%. The aor-
tic annulus was 23 mm.  On transesophageal echocardiogram (TEE),
the aortic valve leaﬂets appeared thickened and calciﬁed with mild
aortic regurgitation. Society of Thoracic Surgeons (STS) and logistic
EuroSCORE were calculated and found to be, respectively, 12 and
35%. The risk of conventional surgery was deemed too high and in
accordance with the cardiac surgeon, a transfemoral approach TAVI
with the implantation of a 26 mm Edwards Sapien (ES) (Edwards
Lifesciences, Irvine, CA, USA) valve prosthesis was planned.
At coronary angiography, all bypass grafts were patent. After
informed consent was obtained and all preventive measures were
taken, the TAVI procedure was performed in the hybrid operating
room under general anesthesia. After the balloon valvuloplasty
was carried out under rapid pacing (Fig. 1, Video 1) a 26 mm ES
aortic valve was  successfully implanted percutaneously through
the left femoral artery. Completion aortic root angiogram showed
mild paravalvular leak and ﬁne seating of the valve (Fig. 2, Video
2). The patient became severely hypotensive 6 h after the pro-
cedure and developed ventricular ﬁbrillation. Cardiopulmonary
resuscitation was  performed. TTE and aortography demonstrated
a dislocated aortic prosthesis into the LVOT (Fig. 3, Videos 3 and
4). The patient was  urgently operated and the prosthesis valve
was removed through the native aortic valve (Fig. 4). The native
aortic valve was mildly calciﬁed and thickened with commissural
fusion. After the complete resection of the native aortic valve, the
vier Ltd. All rights reserved.
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rFig. 1. Aortic valvuloplasty.
ortic annulus was measured as 21 mm.  Surgery was successfully
ompleted with the implantation of a metallic prosthetic valve
nd the patient was discharged from the hospital on the seventh
ay.
iscussion
Although rare, dislocation occurring after TAVI is a serious
omplication and operators must be prepared for it during TAVI
rocedures. Dislocation may  emerge in any implantation approach,
ncluding transfemoral, subclavian, and transapical [4]. It can be
een as 3 different types: infra-annularly (intraventricular), supra-
nnularly, and supra-sinutubular junction (dislocation into the
scending aorta) [5]. A completely implanted dislocated ES pros-
hesis can be retracted into the ascending or descending aorta with
 gooseneck catheter, and a second valve can be implanted in the
nnular position. As in our case and some others, retrieval of the
rosthesis is impossible. This complication may  only be treated
urgically [3,4]. Dislocation is usually caused by initial positioning
rror and utilizing an undersized valve [6]. Therefore, precise annu-
us measurements by echocardiography and if necessary computed
omography (CT) are essential [4]. Our measurements were mainly
ased on echocardiography. However, the values of the aortic annu-
us diameter vary signiﬁcantly in different CT and TEE assessments
nd this matter can be associated with valve dislocation. Indeed,
t has been well recognized that TTE routinely underestimates the
rue annulus diameter compared to TEE or CT [7]. In this case we
xperienced a rare but possible complication of TAVI, although the
ecommended procedural managements were applied. In our case,Fig. 2. Aortography after valve deployment showing ﬁne seating of the valve.
inadequate calciﬁcation to allow the valve to adhere properly might
be responsible for valve dislocation. Recently, there have been two
case reports that described second valve implantation for the treat-
ment of core valve dislocation [5]. Because it does not work, when
the ES valve prosthesis is embolized into LVOT or ventricle, espe-
cially in hemodynamically compromised patients an attempt to
pull the prosthesis for implantation of a second prosthesis is some-
times impossible. Therefore, the patient was taken directly to the
operating room.
The ES prosthetic valve is usually malpositioned supra-
annularly, while embolization, coronary obstruction, and sub-
annular positioning are uncommon [4,6]. For prevention of this
complication, appropriate imaging of the aortic root with angiogra-
phy, TEE, and CT should be performed, with particular attention to
the size and shape of the annulus, as well as the location and distri-
bution of any calciﬁcation [8]. Other factors that may  contribute to
malposition such as suboptimal visualization, lack of burst pacing,
poor timing of balloon inﬂation, lack of predilatation, and interfer-
ence from cardiac structures should also be eliminated [6]. As the
ES prosthesis system is balloon expandable and not repositionable
once expanded, the exact location of deployment must be resolved
and performed in an accurate and careful manner.
Management of infra-annular dislocation depends mainly on
the degree of dislocation and hemodynamic compromise. Deploy-
ment of a second overlapping prosthesis may  be effective although
correct positioning may  be difﬁcult. If the prosthesis is low in the
left ventricular outﬂow tract, it may  not be possible to manage it
with a second overlapping prosthesis and conversion to conven-
tional surgery may  be the only option [6].
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Fig. 3. Aortography showing the dislocated valve into the left ventricular outﬂow
tract.
Fig. 4. The extracted valve.
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Conclusion
TAVI is an alternative or promising treatment option with
speciﬁc procedure- and patient-related complications. Although
dislocation of ES prosthesis can be managed interventionally in
most cases, surgical intervention is inevitable in some cases.
The procedure must be performed in experienced centers with
meticulous diagnostic evaluation to prevent life-threatening com-
plications.
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Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.jccase.
2013.12.007.
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